ABSTRACT

Years of extensive investigation into neurophysiology, neurochemistry, and behavioral pharmacology have produced an understanding of antipsychotic medication action that is much more refined than the original dopamine hypothesis. New perspectives offer an array of novel drugs - drugs that pose a lower risk of developing tardive dyskinesia, have few

chapter 1|16 pages

Schizophrenic Syndromes

chapter 9|16 pages

The Antipsychotic Effects of Sigma Drugs

chapter 10|10 pages

GABAergic Drugs in Schizophrenia